Delivery Order SPE2DB20D1100-SPE2DB22FD0B5
Award Date
8/15/22
Potential Completion Date
9/6/22
Potential Value
$131K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The delivery order, with a potential value of $131,171.40, is for 300 mg/10 ml vials of the drug OCREVUS. The order was placed against an existing contract held by Amerisourcebergen Drug Corp to supply pharmaceuticals and medical supplies to DLA Troop Support...
This is a $109,309.50 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of 300 mg/10 ml vials of the pharmaceutical product OCREVUS. The delivery order was placed against an existing contract vehicle, with no set-aside designation. AmerisourceBergen Drug Corp, as the prime contractor, will provide the pharmaceutical products to support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OCREVUS 300 mg/10 ml vials. The total potential value of the award is $128,918.52, with a completion date of October 15, 2021. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to provide pharmaceuticals, medical supplies, and...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OCREVUS 300 mg/10 mL vials. The order has a potential value of $218,619.00 and a completion date of September 28, 2022. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense. This delivery order is...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The order is for the supply of OCREVUS 300 MG/10 ML VIAL 10ML, a pharmaceutical product, with a potential value of $135,712.32 and a completion date of June 30, 2023. This delivery order is part of Amerisourcebergen's existing indefinite delivery contract with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the delivery of OCREVUS 300 MG/10 ML VIAL 10ML, a pharmaceutical product, with a potential value of $109,309.50 and a completion date of March 3, 2022. Amerisourcebergen Drug Corp, as a prime contractor, has received numerous federal contract awards from DLA to supply pharmaceuticals,...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide OCREVUS 300 MG/10 ML VIAL 10ML pharmaceutical products. The $109,309.50 award has a completion date of March 14, 2022. Amerisourcebergen Drug Corp, as a prime contractor, has received multiple previous federal contract awards from the DLA to supply pharmaceuticals, medical supplies, and related...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order, with a potential value of $113,093.60, is for the supply of OCREVUS 300 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has a completion date of May 9, 2023. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that provides pharmaceutical products and...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OCREVUS 300 MG/10 ML VIAL 10ML. The delivery order has a potential value of $109,309.50 and a completion date of March 3, 2022. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA Troop Support Medical to provide pharmaceutical products...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 300 mg/10 mL vials of the pharmaceutical product OCREVUS. The $163,964.25 award has a completion date of March 10, 2022 and was made on February 16, 2022. Amerisourcebergen Drug Corp is a prime contractor that has received multiple DLA awards to provide pharmaceuticals, medical supplies, and related distribution services in...